Sino Biopharmaceutical | 1177 - Current Liabilities


Sino Biopharmaceutical reported CNY24.85B in Current Liabilities for its fiscal semester ending in June of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 173.88M 10.95M Mar/2026
Alaunos Therapeutics USD 595K 218K Mar/2026
Avita Medical AUD 62.68M 77K Dec/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Dianthus Therapeutics USD 34.39M 3.89M Jun/2026
Ionis Pharmaceuticals USD 315.64M 401.36M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
Jiangsu Hengrui CNY 5.64B 732.51M Mar/2026
Moderna USD 2.53B 139M Jun/2026
Organon & Co USD 2.5B 110M Mar/2026
Revvity USD 1.28B 37.71M Jun/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tectonic Therapeutic USD 12.96M 3.29M Mar/2026
Viatris USD 6.81B 284M Mar/2026
Xeris Pharmaceuticals USD 118.59M 9.02M Mar/2026